All posts by imreal

Florida Elder Law Firm Offers Free Legal Documents for Healthcare Workersin Florida


“As a way to thank healthcare workers personally, we want to make sure that they have the documents that are necessary to provide direction to family and physicians as to their feelings about being kept alive with heroic measures.”

To honor the dedicated and selfless heroes of our healthcare system during the coronavirus, Elder Law Associates PA, an AV® Preeminent-rated elder law firm headquartered in Boca Raton, Florida, is proud to announce it is now offering free legal documents for frontline healthcare workers in South Florida.

Healthcare workers, including nurses, aides, technicians, administrators, discharge planners, home care aides and others who work in hospitals, skilled nursing facilities and assisted living facilities in Florida can receive free drafting of designations of healthcare surrogates and living wills from Elder Law Associates PA exclusively at their Boca Raton, Fla. office. Watch our video here for more information.

“We want to thank our frontline healthcare workers for stepping up, putting their own lives in danger, by continuing to provide much-needed care to the hundreds of thousands of individuals that have been affected by the coronavirus,” said Howard S. Krooks, Esq., CELA, CAP, partner of Elder Law Associates PA. “You are the most amazing heroes, and the entire country and world owes you our deepest gratitude for all of the work that you are doing to beat COVID-19.”

According to Elder Law Associates PA Partner Ellen S. Morris, Esq., “As a way to thank healthcare workers personally, we want to make sure that they have the documents that are necessary – a designation of healthcare surrogate and living will – to enable another individual of the person’s choosing to make healthcare decisions if they’re unable to make it for themselves, and also to provide direction to family and physicians as to their feelings about being kept alive with heroic measures.” She added, “We are going to be doing this as a thank you to frontline healthcare workers for as long as they need the documents during this pandemic.”

Despite the coronavirus outbreak, Elder Law Associates PA remains open and committed to serving clients during regular office hours, Monday through Friday from 8:30 a.m. to 5 p.m., however their physical offices are temporarily closed to the public. The firm is conducting all consultations over the phone or through video conferencing, with document signings taking place outside in their office’s outdoor plaza. For more information, please contact us or call toll-free 1-800-ELDERLAW or (561) 750-3850.

About Ellen S. Morris, Esq.

Ms. Morris is a partner and founder of Elder Law Associates PA, a practice devoted to serving seniors, people with disabilities and special needs and their families as they navigate the complexities of long-term care planning and litigation related to guardianships, estates, trusts and fiduciaries. She is the chairperson of the Litigation Committee of the Elder Law Section and co-chair of the Joint Public Policy Task Force for the Elderly and Disabled on the Elder Law Section of the Florida Bar, and was past chair of the Elder Law Section for six years and held every executive council position of the Florida Bar. She also serves as co-chair of the Elder Law Section of the South Palm Beach County Bar Association. She was selected as a Florida Super Lawyer in 2020, is listed among the Florida Legal Elite, has a 10.0 (Excellent) rating from Avvo, and is AV® Preeminent rated by Martindale-Hubbell, a testament that Ms. Morris’s peers rank her at the highest level of professional excellence.

About Howard S. Krooks, Esq., CELA, CAP

Mr. Krooks is a partner of Elder Law Associates PA and is admitted to practice law in Florida and New York. He is certified as an Elder Law Attorney by the National Elder Law Foundation and a past president of the National Academy of Elder Law Attorneys (NAELA). He also serves on the Executive Council of The Florida Bar Elder Law Section as the NAELA secretary. He was selected as a Florida Super Lawyer and a New York Super Lawyer for 2020, is listed as a Florida Legal Elite, and has a 10.0 (Excellent) rating from Avvo. In addition, he is AV® Preeminent-rated by Martindale-Hubbell, a testament that Mr. Krooks’ peers rank him at the highest level of professional excellence.

About Elder Law Associates PA (https://elderlawassociates.com/)

Elder Law Associates PA is a prestigious elder law firm with offices in Boca Raton, Aventura, Weston and West Palm Beach, Fla., and Rye Brook, New York, practicing exclusively in elder law, including advance directives and estate planning, trust and estate administration litigation, wills and trusts, Medicaid and nursing home planning, Medicaid and VA planning and applications, disability planning, special needs planning, special needs trusts, guardianship, and asset preservation planning. The firm has received an AV® Preeminent Peer Review Rating by Martindale-Hubbell and other accolades. Elder Law Associates PA assists clients in planning for the possibility of disability, incapacity, home health care, assisted living and/or nursing home placement. The firm offers legal counsel with a keen understanding of the needs of families, giving them peace of mind in difficult situations. For more information, contact us at (561) 750-3850, email Info@ElderLawAssociates.com or visit http://www.ElderLawAssociates.com.

Elder Law Associates PA: We give families peace of mind.

###

Share article on social media or email:

KOHLER-SDMO’s Introduces It’s Most powerful Generator Set Ever


Kohler-KD4000 Industrial Generator

We are excited to introduce the New 4500kVA (@50Hz) / 4000kW (@60Hz) diesel powered generator sets, KOHLER’s most powerful systems on the market.

Late 2016, KOHLER-SDMO unveiled its all-new range of large diesel industrial generators powered by an entirely new line of KOHLER diesel engines represented by the K135 and K175 engine families. The generators range from 800kVA/800kWe to 3500kVA (@50Hz) / 3250kWe (@60Hz) respectively.

Today, based on a strong worldwide market response and an increasing demand on power in mission critical applications, KOHLER-SDMO is proud to officially expand the KD Series with the rollout of 4 new models ranging up to 4500kVA (@50Hz)/ 4000kWe (@60Hz). Developed by our global team of Engineers these new units are powered by our latest most powerful and sophisticated K175 engine, the KD103V20. This release expands the limits of standby generators and sets KOHLER apart as the most powerful diesel genset manufacturer in the market.

Building on the excellence of the KD Series product line these generators are designed to deliver extreme durability and ultimate reliability in a variety of emergency and prime applications. The modular design of the KD103V20 powered generator sets deliver unprecedented power density and unrivaled performance. Matched turbochargers are engineered for maximum power and response. High ambient cooling systems ensure performance is maintained in the most extreme environments. Fuel mapping options for either optimized consumption or emissions compliance enable the generators to be deployed globally without worry. Users of the KD Series generators will find cost savings because the line delivers the best fuel consumption at more nodes than any other competitor. KOHLER’s proprietary advanced control and communication system ties the entire system together for a seamless customer experience.

When paired with KOHLER’s global sales and support network the KD Series line-up provides leading performance for mission critical and industrial applications. Data centers, healthcare facilities, water utilities, and critical facilities such as airports; can rest assured with a KD Series generator set backed by KOHLER’s Worldwide support network. And when service is needed, KOHLER has a global dealer and distribution infrastructure consisting of more than 800 facilities offering 24/7 parts availability.

The new KD Series products will be available for sale in June.

For more information, visit kdseries.com and watch the video.

About KOHLER-SDMO.

Founded in 1966, KOHLER-SDMO is today the leader in France and the 3rd largest manufacturer of generating sets worldwide. The company designs, manufactures and markets standard generating sets ranging from 1 kVA to 4500 kVA, which meet all power requirements and adapt to all applications. KOHLER-SDMO also puts its engineering expertise into practice to meet the most specific demands by designing tailor-made power plants. The company offers a complete turn-key service: from the design of the power plant to its installation, including on-site maintenance services. The dynamism of its customer services policy thereby guarantees the long-term operability of its facilities throughout the world.

About KOHLER Power.

A global force in power solutions since 1920, KOHLER is committed to reliable, leading-edge products and comprehensive after-sale support. KOHLER’s acquisition of SDMO in 2005 created one of the world’s largest manufacturers of generators and power solutions. The companies collectively have more than 150 years of experience in industrial power and now benefit from global R&D, manufacturing, and sales and service. For additional information, please visit kohlerpower.com or kohler-sdmo.com

Share article on social media or email:

MicroGenDX Receives FDA Emergency Use Authorization for COVID-19 Test to Expand Testing Capacity


The hurdles to COVID-19 testing have been daunting. We speak daily with governors, business owners and hospital administrators looking for better options. The additional support of the FDA through its EUA opens the door for us to meet the demand and utilize our full testing capacity.

MicroGenDX Laboratories, the world leader in providing PCR and Next Generation DNA Sequencing in microbial identification, has received FDA Emergency Use Authorization for its validated real-time Reverse Transcriptase PCR (rRT-PCR) assay for detecting the SARS- CoV-2 virus.

Increasing evidence supports the use of sputum and saliva for rapid and accurate detection of SARS-CoV-2. Since late March 2020, MicroGenDX has collected and tested the largest sampling of saliva and sputum (more than 14,000 tests) and ongoing analysis continues to find these samples to be high-quality and more sensitive than nasal samples. A recent study out of Yale also found saliva to be more sensitive for SARS-CoV-2 detection in patients than nasopharyngeal swabs.

The test allows patients to self-collect sputum, a mucus-like mixture of saliva and other elements that come from the respiratory tract. Additionally, the EUA is granted for the lab’s testing with NP swabs, of which the lab has performed more than 16,000 tests. However, due to supply shortages for swabs and PPE (Personal Protective Equipment) and in light of mounting scientific validation, the lab sees greater potential for increased sputum and saliva testing. MicroGenDX is currently performing the requested paired sample analysis for its saliva-only test and anticipates FDA support on it in the near future.

MicroGenDX is listed on the FDA Website as a resource laboratory for COVID-19 Testing as “Southwest Regional PCR dba MicroGenDX Laboratory.”

MicroGenDX was one of the first national laboratories to validate and compare the testing of a variety of sample sources: sputum, saliva and nasopharyngeal (nasal). As a high-complexity lab developing and processing its own validated Laboratory Developed Test (LDT), and not a test kit, all of the lab’s COVID-19 tests are validated under its Clinical Laboratory Improvement Amendments (CLIA) license. However, MicroGenDX sought EUA from the FDA to further clarify the validity of the test for hospitals, clinicians and patients.

“We continue to work tirelessly to make a significant impact on the testing crisis. The hurdles to COVID-19 testing have been daunting. We speak daily with governors, business owners and hospital administrators looking for better options. The additional support of the FDA through its EUA opens the door for us to meet the demand and utilize our full testing capacity. We have bolstered our existing diagnostic teams to scale testing in accordance with the growing influx of tests we’ve started performing since last month,” said Rick Martin, CEO of MicroGenDX.

For more information on how to receive tests, please visit https://microgendx.com/covid19/.

Additional Test Information

The benefits of increased saliva and sputum testing are immense. These tests do not require swabs and other supplies that are experiencing a shortage. A provider does not have to perform the sample collection, thus decreasing patient-to-provider transmission of the virus. The patient does not suffer an uncomfortable collection experience.

In addition to a simplified collection process, MicroGenDX’s testing turnaround is 24-hours, eliminating the chances that the RNA will break down waiting for processing, which has led to false negatives for tests at other laboratories.

MicroGenDX runs its COVID-19 Rapid PCR Test at its diagnostic laboratory in Lubbock Texas, and accepts samples from every state.

About MicroGenDX

MicroGenDX is the global leader in molecular testing services through PCR and Next Generation DNA Sequencing to identify microbes in human samples having run more than 400,000 DNA tests over the last 12 years. We are a state-of-the-art, CAP- accredited, CLIA-licensed Molecular Diagnostic facility backed by a team of molecular biologists, biochemists, bioinformaticians, computer scientists, and physicians. Our advanced instrumentation provides the industry’s most informative microbial diagnostic tests for ENT, orthopedic, urology, wound care, OB/GYN and other areas of medicine.

Media Contact:

AM Public Relations for MicroGenDX

Ashley Moore

amoore@ampublicrelations.com

Jessica Garcia

jgarcia@ampublicrelations.com

Share article on social media or email:

Mesa Science Associates and Bryn Pharma Publish Second Pre-Clinical Study of a New Approach to Treating Anaphylaxis


News Image

Mesa Science Associates Inc. (MSA) and Bryn Pharma LLC published the findings from the second of three (3) pre-clinical studies conducted in beagle dogs. These studies establish that epinephrine is readily absorbed when administered intranasally and has advantages over an intramuscular injection of epinephrine. The pre-clinical study was managed by MSA and was conducted at MRI Global Laboratories in Kansas City, MO. The study was funded by Bryn Pharma LLC of Raleigh, NC. The study was published in Pharmacology Research and Perspectives and is entitled Intranasal Epinephrine in dogs: Pharmacokinetic and heart rate effects.

The second study found that epinephrine administered intranasally was well-tolerated and had advantages when compared to epinephrine via auto-injector (intramuscularly). Intranasal epinephrine administration resulted in a more rapid increase in plasma epinephrine concentration within the first five minutes and produced less increases in heart rate over time when compared to intramuscular injection.

This study involved single doses of intranasal epinephrine given to dogs in doses of 2, 3, 4, 5, 10 and 20 mg. Intramuscular administration of epinephrine was given at doses of either 0.15 or 0.3 mg to the bicep of the dogs using an autoinjector. Three plasma samples were collected before dosing, and after administration at the intervals of 1, 5, 10, 15, 20, 30, 60, and 90 minutes. Electrocardiogram measurements were also used to monitor and record the heart rates at the same intervals. No anesthesia was required for administration of the doses. Increasing intranasal dosing from 2 to 20 mg resulted in a dose-related increase in plasma concentrations of the drug. No significant adverse effects were noted in the dose range of 2 to 10 mg. An intranasal dose of 2 mg produced plasma levels that were similar to those observed with 0.15 mg given by intramuscular administration. Similarly, 4 and 5 mg intranasally resulted in plasma levels that closely approximated the intramuscular administration of 0.3 mg.

Dogs are an advantageous species for clinical translation (pre-human trials) because of the similarities in the nasal environment of dogs and humans. These include similar nasal volume, dimension, surface area, and clearance. During the course of the three canine studies no animals we injured and at the conclusion of the studies all animals were adopted into forever homes.

The overall study offers an alternate route of administration for epinephrine, via the nostril, reducing the anxieties that come along with an auto-injector and the associated hypodermic needle injection. There are known advantages of intranasal administration, but the literature regarding its use is limited. Intranasal administration of epinephrine could lead to increased usage versus an auto-injector, with less hesitation for use in patients with severe allergies.

Anaphylaxis is a serious and sometimes life-threatening allergic reaction where the immune system overreacts to an allergen by releasing histamines that cause allergy symptoms. In severe cases if anaphylaxis isn’t properly treated, it can be fatal. Rates of such reactions have increased over the last 20 years and are usually treated by administering epinephrine into a muscle with an auto-injector.

Michael Mesa, CEO of Mesa Science Associates, is anticipating the publication of the last of three (3) studies this spring. These pre-clinical studies preceded human studies which were started in 2019 and are planned for completion over the coming summer. The planned clinical studies will further investigate intranasal epinephrine pharmacokinetic and pharmacodynamic effects. Mr. Mesa stated that “These study results are the cumulation of effective partnering with Bryn Pharma and Mesa Science Associates and is just another example of the exceptional achievements that have resulted from effective collaboration between our two companies on this program.” He also noted that “during the conduct of these studies no animal was injured and all study animals were adopted into forever homes.”

In addition to the pre-clinical studies, MSA continues to provide support for Bryn Pharma nasal product development activities including device activities, identification of a contract fill and finish source, and coordination with the fill and finish source for Chemistry, Manufacturing and Controls activities. MSA also utilizes its extensive list of pharmaceutical experts to provide advice on a variety of manufacturing, clinical, quality, technical and scientific issues.

Mesa Science Associates is a pharmaceutical product development company located inside the Frederick Innovation and Technology Center Inc. (FITCI) in Frederick, MD. The mission of the company is to provide technical and scientific expertise to researchers from all aspects of the drug, drug delivery and product development community, including researchers from government, academia, as well as private entities.

For more information on Mesa Science Associates visit http://www.mesascience.com/

Share article on social media or email:

Employment BOOST To Provide $10,000 Worth Of Professional Resume Writing Packages To Family of Frontline Healthcare Workers Fighting The COVID-19 Crisis


News Image

“We want to say thank you to all the brave and talented frontline healthcare workers helping to fight the global COVID-19 crisis.”

Employment BOOST is saying thank you to frontline healthcare workers by assisting family members whose jobs have been affected by the coronavirus pandemic and offering free 5-star-rated professional resume writing and job search assistance. Employment BOOST has committed $10,000 worth of resources as part of the initiative.

Until June 30, individuals can call into (888) 468-6495 to speak with the Employment BOOST team and sign up for the free packages.

One of the highest-rated professional career services firms in the country, Employment BOOST’s free resume writing packages will include:


  • One-on-one consultation with a Certified Professional Resume Writer
  • Brand new professional resume
  • Customizable cover letter
  • LinkedIn profile development
  • Complimentary thank you letter

“We want to say thank you to all the brave and talented frontline healthcare workers helping to fight the global COVID-19 crisis,” said William Ratliff, Senior Career Services Manager at Employment BOOST. “Knowing how fragile the job market is at the moment, the least we can do as career services professionals is lend a helping hand the best way we know how.”

With more than a decade of career services experience, Employment BOOST’s professional resume writing services begin with a one-on-one consultation with a Certified Professional Resume Writer, who will guide the process of creating a brand-new polish professional resume, cover letter, LinkedIn profile, and thank you letter. Employment BOOST has offices in Michigan, Illinois, Colorado, New York, and Ohio. The services will be conducted over the phone or teleconference.

“We understand how difficult and stressful it is to look for a job in any market, let alone a global pandemic,” said Dennis Theodorou, Managing Director of Employment BOOST. “We encourage anyone who is having difficulty with their job search to reach out and take advantage of these free resume writing packages. We want to help those who are risking everything for the rest of us.”

Individuals looking to access the free professional resume writing packages can call into (888) 468-6495 to speak with the Employment BOOST team and sign up.

About Employment BOOST:

Employment BOOST is a Troy, Michigan and Chicago, Illinois based company that provides professional resume writing services and critiquing, executive resume services, cover letter development, resume distribution, social media profile creation, and interview coaching to job seekers across the nation. For more than a decade, Employment BOOST has consistently been helping people achieve career satisfaction. Employment BOOST uses talented industry experts to tailor resumes to the key content that hiring managers seek. For more information on Employment BOOST, please call 888-468-6495 or visit https://employmentboost.com.

Share article on social media or email:

Telemedicine Solutions’ Game-Changing App Connects Nursing Homes, Physician Practices and Other Healthcare Providers with Patients During the COVID-19 Pandemic


Telemedicine apps are built for quick and easy clinician-patient connection

We have used the most battle-tested technology to ensure that MyHealthCoach is the right telemedicine platform for remote care delivery.

The New York Times reported on Friday, Apr. 17, 2020 that 20% of all COVID-19 virus deaths were related to nursing homes. In addition, The New York Times review of COVID-19 cases revealed an astonishing 36,500 nursing home residents and staff contracted the virus. The MyHealthCoach app has been a game-changing ally in the hands of Healthcare workers who have been stretched to their limits in their efforts to halt the spread of infection and to meet the increased demands of caring for vulnerable patients within facilities and in surrounding communities.

Widespread reports of staffing shortages at healthcare facilities caused by workers falling ill or being forced to quarantine at home have created increased opportunities for off-site physicians and other remote clinicians to step up to fill gaps for residents and patients in need of medical attention via telemedicine technologies. The MyHealthCoach app’s innovative design simplifies team-centric workflow, enabling quick and easy video telemedicine consults and text-based communication between caregivers and patients. In addition, MyHealthCoach can be a powerful tool for rounding clinicians— such as attending physicians, to sustain their practice via safe and efficient “virtual rounds” to patients and residents in a wide range of healthcare facilities.

“We have been staying extra close to our customers amidst this formidable crisis. Each day, we hear countless stories of the extraordinary challenges our post-acute partners face,” said Mike Diamond, Telemedicine Solutions CEO. “We have used the most battle-tested technology to ensure that MyHealthCoach is the right telemedicine platform for remote care delivery. It gives teams easy-to-use dashboards that coordinate patient communication and video consults in record time —no matter the location.”

Telemedicine Solutions LLC is a mobile health technology company with a mission to improve the quality of life for people living with chronic diseases via simple apps designed to reduce the costs of care delivery and optimize patient care. The MyHealthCoach app streamlines clinical workflows and enables text, image, and secure video connection with patients. MyHealthCoach also allows clinicians to actively partner with their patients to alleviate chronic disease through easy and secure communication around shared health measures, tracking progress with care plan compliance and wellness goals, and patient education.

For more information about MyHealthCoach, visit: https://www.getmyhealthcoach.com

Tags: telemedicine, COVID-19 virus, nursing homes, virtual rounds, telehealth

Contact: Rhett Gustafson, Exec. Vice President, Finance and Strategic Development / 847-519-3500

Photo credit: © verbaska / Adobe Stock

Share article on social media or email:

Atlantic Data Forensics Offers Free Computer Incident Response Services To Healthcare Organizations


Atlantic Data Forensics Logo

Atlantic Data Forensics, Inc.

In response to an unprecedented increase in ransomware and data breach activity during the COVID-19 pandemic, Atlantic Data Forensics, Inc. announced today that it will provide Digital Forensics/Incident Response (DFIR) services to US-based healthcare organizations and first responders whose COVID-19 related patient care and other front-line systems have been compromised by cybercriminal activity.

During this time of disruption, emergency expansion and resource limitation for healthcare providers dealing with the impact of COVID-19, cybercriminals have stepped up their attacks on those same providers through phishing and probing networks in an effort to profit from disabling hospital computer systems through ransomware, stealing patient healthcare data or furthering financial fraud schemes.

Last week the FBI reported through their Internet Crimes Complaint Center (IC3), that since the beginning of the COVID-19 pandemic, the Bureau has seen the number of incidents reported increase from 1,000 per day to upwards of 4,000. Likewise, Atlantic Data Forensics has responded to a significant increase of cybersecurity incidents due to increased cybercriminal activity during the pandemic.

“After looking at current cyber threat intelligence and our own surge in incident response activity, I realized the company could help by providing free services to not only our healthcare clients that are under increased attack, but to all healthcare organizations currently on the front lines of this battle.” said Brian Dykstra, CEO, of Atlantic Data Forensics, “I chose to present this offering to the healthcare community because, like many other people, I’ve been challenged in trying to find a way to contribute and directly assist health care professionals during this pandemic.”

Atlantic Data Forensics has a team of experienced, computer incident responders and computer forensic examiners that are the choice of many of the nation’s largest businesses, law firms, government agencies and non-profit organizations.

If you would like more information about this topic, please call Patrick Wynn at (410) 540-9000 x110 or email contact@atlanticdf.com

Share article on social media or email:

MediTelecare Launches MediStaffCare To Help Frontline Workers Facing Unprecedented Pressures


MediStaffCare

In these uncertain times, it’s important that we not only care for residents but for the staff that provides essential care to them. We are especially concerned for our colleagues on the frontlines and hope that by increasing access to telehealth, these individuals will get the help they need…

The emotional cost of caring for others is a known occupational hazard as physicians, nursing staff, and social workers spend countless hours caring for others. In these uncertain times of the COVID-19 pandemic, skilled nursing facilities especially are facing insurmountable challenges when it come to the well-being of their staff and residents.

The staff at these facilities are experiencing repeated exposure to illness and suffering at an unprecedented level and without access to mental health treatment, emotional distress can be exacerbated. This can then lead to depression, anxiety, post-traumatic stress, and substance abuse. The team at MediTelecare understand these risks and has launched MediStaffCare in response.

MediStaffCare can be leveraged by frontline workers at a time and place that is safe and convenient for them. These televideo sessions not only will help to minimize the risk of office visits during this outbreak, but it will also allow these individuals to address their own wellness needs with mental health providers who understand the struggles they face on a daily basis.

MediStaffCare enables the following:


  • Access to care during the Coronavirus outbreak via its secure telehealth platform
  • Avoidance of outpatient settings
  • Supportive psychotherapy with qualified clinical psychologists and social workers who have expert knowledge of the skilled nursing industry
  • Private sessions made easily available through a home computer
  • MediTelecare will contract with the facility’s insurance carrier and is credentialed with most major panels

“In these uncertain times, it’s important that we not only care for residents but for the staff that provides essential care to them. We are especially concerned for our colleagues on the frontlines and hope that by increasing access to telehealth, these individuals will get the help they need to continue providing care for their residents.” – Ed Mercadante, CEO

During a crisis like this when face-to-face treatment is not an option due to the high risk of spreading the infection, telehealth is a necessary means to ensure everyone receives the care they deserve.

About MediTelecare: MediTelecare is the industry leader in providing behavioral telehealth services to residents of skilled nursing and assisted living facilities. The company’s clinical team consists of psychiatrists, nurse practitioners, psychologists, and clinical social workers providing behavioral telehealth services to approximately 20,000 residents in over 250 Skilled Nursing Facilities (SNF) across 16 states. MediTelecare services utilize synchronous televideo with face-to-face communication and other virtual telemedicine technologies to streamline diagnostic evaluations and design personalized treatment plans for each resident’s needs.

Share article on social media or email:

Leefy Organics Will Participate In the Biggest Health Space Giveaway This Year on Instagram


News Image

“We’re doing our best to help those in the front lines who are putting themselves at risk every day to help all of us,“ Kuran added.

Leefy Organics Will Participate In the Biggest Health Space Giveaway This Year on Instagram

In addition to donating their turmeric-based elixir PRANA to the medical community, Leefy Organics will be surprising some lucky social media followers.

Leefy Organics, maker of the great tasting, bioavailable turmeric and ginger supplement PRANA is joining forces with three other innovative products in the ultimate Instagram health and wellness giveaway. Sports Illustrated model and influencer Camille Kostek will host the event the week of Monday, April 27th choosing multiple winners.

Giveaway partners include health appliance innovator Tribest, contributing three $700 juicers; the indoor allergen air purifier Airdoctor, giving away two $650 air filters; and the at-home purified water system AquaTru, supplying one $300 water filter. Leefy Organics will surprise 20-30 winners with the signature PRANA elixir and some fun swag.

Brand founder and certified holistic nutritionist Carl Kuran is a fan of Kostek. As a Boston native, he admires the donation work she’s been coordinating within his locale during this pandemic. Kuran was further inspired when Kostek and her significant other, former New England Patriots player Rob Gronkowski donated 10,000 masks to Boston area hospitals.

He has since launched his own initiative giving back to some hard-working medical professionals who could use some immune-boosting turmeric and ginger.

“My niece is an RN at a hospital in Ohio and we already sent 10 bottles to their team of nurses because we realized they need to boost their immunity,” Kuran said.

“We’re doing our best to help those in the front lines who are putting themselves at risk everyday to help all of us,“ Kuran added.

At a time when everyone is monitoring their health and immune system, PRANA is the only organic, non-GMO, vegan and gluten-free formula providing superior absorption of much-needed nutrients in an easy-to-take liquid form. The elixir is best known for combatting congestion, inflammatory pain and poor digestion among other ailments.

About Leefy Organics: Carl Kuran is the certified holistic nutritionist and founder of Leefy Organics. As a firm believer in holistic healing and a passion to help others heal themselves, his attention turned to his mother’s health. She had such severe mucus congestion she couldn’t breathe or sleep, and her doctors weren’t finding a medical solution. While anti-inflammatory foods turmeric and ginger provided some relief, it wasn’t enough. After research and experimenting with different formulations, Kuran came to a breakthrough in more effective turmeric absorption. This miracle formula later became known as Prana, the signature product of Leefy Organics.

Share article on social media or email:

Strategies to Build Patient-Centric Clinical Supply Chains to be Presented by Catalent Experts at Upcoming Virtual Conferences


Catalent, a global leader in clinical supply services, today announced that two of its experts will present at upcoming virtual industry conferences: CPhI North America Webinar Week; and Clinical Trial Supply 2020 – A Virtual Experience.

During the CPhI North America Webinar Week, Nicole Gray, Director, Strategic Supply Solutions and Stephen Flaherty, Global Director, Strategic Supply Solutions will present “Managing the Changing Landscape: Building a Flexible, Challenge-Resistant and Patient-Centric Clinical Supply Chain”. The webinar, on Wednesday, May 6, at 11 a.m. EDT, will explore strategies to improve supply chain efficiency, while responding to local, regional and global challenges. Ms. Gray and Mr. Flaherty will also discuss supply models that can be used to improve flexibility and better align with patient needs, as well as presenting a case study that demonstrates the impact that these patient-centric strategies can have on clinical supplies.

According to Catalent’s own research, that surveyed sponsors’ perspectives on direct-to-patient (DTP) clinical supply, more than 60% of respondents felt that it was important or very important to be able to offer a DTP option for future studies in the U.S., while 54% felt to do so would be important, or very important for the successful operational execution of their study. On May 12, 2020, during the Clinical Trial Supply 2020 – A Virtual Experience, Ms. Gray will present “Direct-to-Patient Clinical Supply: Industry Perceptions & Practical Applications”. Her presentation, at 2:10 p.m. EDT, will further explore the results of this survey, the different DTP models that are currently in use, and scenarios in which individual models or a hybrid approach, may be most effective.

Ms. Gray has more than 15 years’ experience in the pharmaceutical industry across multiple roles in clinical supplies and project management. In her current role at Catalent, she is responsible for leading the DTP business and new strategic service offerings.

Mr. Flaherty has 30 years’ experience across several clinical supplies roles, predominantly focused on project management (PM), and previously had responsibility for PM teams in the U.K. and Germany. As Global Director, Strategic Supply Solutions at Catalent, he is responsible for leading a team of global project managers to deliver a number of key innovative supply chain solutions across the Catalent global network.

For further information on these events, please visit: https://www.clinical.catalent.com/news-and-events/#events

About Catalent Clinical Supply Services

Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries, Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,500 people, including approximately 2,400 scientists and technicians, at more than 40 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email: